Search - tctmd.com

Displaying 1 - 20 of 24

Sort: Relevancy | Date

Presentation TCT 2025

DAPT -Shock-AMI with use of Cangrelor

Presenter: Babar Basir

October 28, 2025

Presentation TCT 2025

TCT 63: Clinical Outcomes of Early Versus Late DAPT Initiation in NSTEACS: A Propensity-Matched TriNetX Cohort Study

Presenter: Muhammad U. Khan

October 28, 2025

Presentation TCT 2025

TCT 1013: Incidence of in-stent thrombotic events in patients undergoing percutaneous coronary intervention (PCI) with stent placement started on dual antiplatelet therapy (DAPT)

Presenter: Sulayma Naser Agha

October 28, 2025

Presentation TCT 2025

TCT 999: One- versus three-month DAPT in patients at high or very high bleeding risk undergoing PCI: Results from the XIENCE Short DAPT Program

Presenter: Davide Cao

October 27, 2025

Presentation TCT 2025

TCT 996: One-versus three-month DAPT in High Bleeding Risk Patients With or Without Baseline Anemia Undergoing PCI

Presenter: Francesca Maria Di Muro

October 27, 2025

Presentation TCT 2025

TCT 55: A Meta-Analysis on Safety and Efficacy of P2Y12 Inhibitor Monotherapy versus Aspirin Monotherapy After 12 Months of DAPT in Patients Post Percutaneous Coronary Intervention

Presenter: Asna Aafreen

October 26, 2025

Presentation TCT 2025

Clopidogrel Monotherapy Following 1-Month DAPT vs. Aspirin Monotherapy Following 12-Month DAPT After PCI in ACS Patients: Final 5-Year Results of the STOPDAPT-2 ACS Trial

Presenter: Hirotoshi Watanabe

October 25, 2025

Presentation TCT 2025

Aspirin Monotherapy After 1-Month DAPT in High Bleeding Risk Patients Undergoing PCI: The TARGET SAFE Randomized Trial

Presenter: Miaohan Qiu

October 25, 2025

Podcast Heart Sounds

Top Cardiology News for September 2025

September 24, 2025

News Daily News

For Monotherapy, P2Y12 Inhibitor Bests Aspirin After PCI for ACS: Meta-analysis

Yael L. Maxwell

August 14, 2025

News Daily News

SCAI/HRS Issue First Practice Guideline for LAAO

Yael L. Maxwell

August 06, 2025

Presentation NY Valves 2025

Outcomes in Patients Discharged on OAC vs. DAPT After Left Atrial Appendage Occlusion Using a Fluoropolymer Coated Device: A Sub-analysis of the HEAL-LAA Post Approval Study

Presenter: Seun Alli

June 25, 2025

News Daily News

Fewer MACCE With P2Y12 Inhibitor vs Aspirin Monotherapy Over 5 Years

Yael L. Maxwell

June 09, 2025

News Conference News EuroPCR 2025

Short DAPT All That’s Needed With Contemporary DES: HOST-IDEA at 3 Years

Yael L. Maxwell

June 02, 2025

News Conference News EuroPCR 2025

Short DAPT Safe in ACS With No Ischemic Penalty: 4D-ACS

L.A. McKeown

May 30, 2025

News Conference News EuroPCR 2025

FLAVOUR Confirms Long-term Noninferiority of FFR vs IVUS to Guide PCI

Yael L. Maxwell

May 30, 2025

News Conference News EuroPCR 2025

Short DAPT in High-Bleeding-Risk Patients Reduces Recurrent Events: MASTER DAPT

Yael L. Maxwell

May 23, 2025

News Conference News EHRA 2025

SWISS-APERO at 3 Years: Hints of Differences Between Amulet, Watchman Emerge

Todd Neale

April 09, 2025

News Daily News

SCAD Story Fleshed Out by Clues About Causes, Treatment Risks

Yael L. Maxwell

March 13, 2025

News Conference News CRT 2025

Need for Rethink of Discharge Medications After LAA Closure? EMERGE

L.A. McKeown

March 12, 2025

Advertisement

DAPT -Shock-AMI with use of Cangrelor

TCT 63: Clinical Outcomes of Early Versus Late DAPT Initiation in NSTEACS: A Propensity-Matched TriNetX Cohort Study

TCT 1013: Incidence of in-stent thrombotic events in patients undergoing percutaneous coronary intervention (PCI) with stent placement started on dual antiplatelet therapy (DAPT)

TCT 999: One- versus three-month DAPT in patients at high or very high bleeding risk undergoing PCI: Results from the XIENCE Short DAPT Program

TCT 996: One-versus three-month DAPT in High Bleeding Risk Patients With or Without Baseline Anemia Undergoing PCI

TCT 55: A Meta-Analysis on Safety and Efficacy of P2Y12 Inhibitor Monotherapy versus Aspirin Monotherapy After 12 Months of DAPT in Patients Post Percutaneous Coronary Intervention

Clopidogrel Monotherapy Following 1-Month DAPT vs. Aspirin Monotherapy Following 12-Month DAPT After PCI in ACS Patients: Final 5-Year Results of the STOPDAPT-2 ACS Trial

Aspirin Monotherapy After 1-Month DAPT in High Bleeding Risk Patients Undergoing PCI: The TARGET SAFE Randomized Trial

Top Cardiology News for September 2025

For Monotherapy, P2Y12 Inhibitor Bests Aspirin After PCI for ACS: Meta-analysis

SCAI/HRS Issue First Practice Guideline for LAAO

Outcomes in Patients Discharged on OAC vs. DAPT After Left Atrial Appendage Occlusion Using a Fluoropolymer Coated Device: A Sub-analysis of the HEAL-LAA Post Approval Study

Fewer MACCE With P2Y12 Inhibitor vs Aspirin Monotherapy Over 5 Years

Short DAPT All That’s Needed With Contemporary DES: HOST-IDEA at 3 Years

Short DAPT Safe in ACS With No Ischemic Penalty: 4D-ACS

FLAVOUR Confirms Long-term Noninferiority of FFR vs IVUS to Guide PCI

Short DAPT in High-Bleeding-Risk Patients Reduces Recurrent Events: MASTER DAPT

SWISS-APERO at 3 Years: Hints of Differences Between Amulet, Watchman Emerge

SCAD Story Fleshed Out by Clues About Causes, Treatment Risks

Need for Rethink of Discharge Medications After LAA Closure? EMERGE

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content